PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2026Medicine Research and Clinical Practice0 citations

Impact of subclinical hypothyroidism on coronary artery calcium score in the elderly: A Comprehensive review and integrated treatment algorithm

View Full Paper
RGRahul Garg

Key Points

  • This review aims to explore the relationship between subclinical hypothyroidism and coronary artery calcium scores in elderly individuals.
  • Examined existing studies linking subclinical hypothyroidism to coronary artery calcium scores.
  • Discussed underlying mechanisms including lipid metabolism, endothelial dysfunction, and inflammation.
  • Reviewed individual treatment considerations based on thyroid-stimulating hormone levels and cardiovascular risk factors.
  • SCH patients exhibit significantly higher CAC scores compared to euthyroid controls, indicating greater coronary calcification.
  • Altered lipid metabolism and chronic inflammation were identified as mediators of increased CAC scores.
  • CAC scoring may improve cardiovascular risk assessment in elderly SCH patients, enhancing personalized treatment strategies.

Abstract

ABSTRACT Subclinical hypothyroidism (SCH), characterized by elevated thyroid-stimulating hormone levels (typically >4.5–5.0 mIU/L) with normal free thyroxine concentrations, affects 3%–16.9% of the general Indian population, with prevalence increasing substantially with age, particularly among women. This comprehensive review examines current evidence linking SCH to coronary artery calcium (CAC) scores in elderly individuals, exploring underlying pathophysiological mechanisms, diagnostic considerations, and clinical implications. Multiple studies demonstrate that SCH patients have significantly higher CAC scores compared to euthyroid controls, with increased prevalence of moderate to severe coronary calcification (CAC >100–400). The relationship is mediated through multiple mechanisms, including lipid metabolism alterations (elevated low-density lipoprotein cholesterol LDL-C and oxidized LDL), endothelial dysfunction with impaired nitric oxide production, chronic low-grade inflammation (elevated C-reactive protein, interleukin-6), and direct vascular effects promoting calcium deposition. CAC scoring provides an objective assessment of atherosclerotic burden and may enhance cardiovascular risk stratification in elderly SCH patients, particularly identifying high-risk individuals misclassified by traditional risk scores like Framingham. Treatment decisions remain individualized based on age, thyroid-stimulating hormone levels, symptoms, and cardiovascular risk factors, with CAC scoring potentially guiding personalized therapeutic strategies in this vulnerable population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rahul Garg (2026) studied this question.

synapsesocial.com/papers/69eb0cb2553a5433e34b5afchttps://doi.org/10.4103/mrcp.mrcp_3_26
Ask AI
Helpful
Bookmark
Share
View Full Paper